Enterprise Value
23.03M
Cash
18.21M
Avg Qtr Burn
-10.71M
Short % of Float
12.17%
Insider Ownership
1.34%
Institutional Own.
5.64%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Sulopenem Details Urinary tract infection | PDUFA Approval decision | |
Sulopenem Details Urinary tract infection | PDUFA Adcomm | |
Sulopenem Details Intra-abdominal infections | Failed Discontinued | |
Sulopenem Details Urinary tract infection | Failed Discontinued |